Home > Healthcare > Pharmaceuticals > Finished Drug Form > Carbapenem Market

Carbapenem Market Share

Report ID: GMI9836
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Carbapenem Market Share

The carbapenem sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Carbapenem Market Companies

Some of the eminent market participants operating in the carbapenem industry include:

AstraZeneca PLC
Aurobindo Pharma
Daewoong Pharmaceuticals Co., Ltd.
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
Kopran Limited
Lupin Limited
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Shenzhen Haibin Pharmaceutical Co. Ltd.
Sun Pharmaceutical Industries Ltd.
The Menarini Group
Venus Remedies Ltd.
Viatris Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The carbapenem market size was valued at USD 4 billion in 2023 and is estimated to grow at 5% CAGR from 2024 to 2032, driven by the rising incidence of antimicrobial resistance.

The urinary tract infections segment of the market accounted for USD 1.4 billion in 2023 and will grow at a robust pace through 2032, as carbapenem has a fast-acting bactericidal effect, which helps quickly reduce bacterial load and alleviate symptoms.

U.S carbapenem market size will reach USD 986.9 million by 2032, owing to rising pharmaceutical innovation.

Aurobindo Pharma, Daewoong Pharmaceuticals Co., Ltd, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Kopran Limited, Lupin Limited, Merck & Co., Inc, Novartis AG, and Pfizer Inc. among others.